Fundraising FoxClearSight Therapeutics
2 known investors
Find your way into ClearSight Therapeutics
Sign up to see every warm intro you have to ClearSight Therapeutics
- Paths you didn't know you had: your email and LinkedIn already hold routes to the ClearSight Therapeutics team. We find them for you
- 2nd- and 3rd-degree connections: the friend-of-a-friend routes that take hours to manually find through your inbox or LinkedIn
- Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone
Days of research, done the moment you sign in, with every route ranked by how warm it is.
ClearSight Therapeutics develops over-the-counter ophthalmic products for common eye conditions such as dry eye, contact lens dryness, and conjunctivitis, working within FDA OTC monograph pathways. Its formulations aim to support ocular surface lubrication and moisture retention for consumers experiencing eye discomfort.
Founders & leadership
PS
Patrick SmaleCofounder & CEO
SA
Suchismita AcharyaCofounder & Clinical Development Lead
NJ
Nuria JimenezChief Scientific Officer
Investors · 2
Health Wildcatters✓ confirmed by ClearSight TherapeuticsDallas
How we know: Health Wildcatters's portfolio page · a partner's Signal profile · Not right? Tell us
Frequently asked questions
- What does ClearSight Therapeutics do?
- ClearSight Therapeutics develops over-the-counter ophthalmic products for common eye conditions such as dry eye, contact lens dryness, and conjunctivitis, working within FDA OTC monograph pathways. Its formulations aim to support ocular surface lubrication and moisture retention for consumers experiencing eye discomfort.
- Who founded ClearSight Therapeutics?
- ClearSight Therapeutics was founded by Patrick Smale, Suchismita Acharya.
- Who are ClearSight Therapeutics's investors?
- ClearSight Therapeutics's investors include Health Wildcatters, Capital Factory.